NEW YORK, July 31 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS) has announced that it has broadened its network of adult stem cell collection centers. Through a development agreement with Stem Collect LLC, NeoStem has added the Hall Center, a vibrant Santa Monica based medical practice.
The Los Angeles area is a significant healthcare market with many academic medical centers and a large concentration of physician practices and hospitals offering a dynamic and diverse population that focuses on healthcare and wellness, as well as new healthcare technologies. To prepare for the demand for collections at the new center, clients are being offered the opportunity to join a waitlist by contacting NeoStem at 1-888-STEM BANK to hold a priority position for an appointment once the center is open. It is expected that the center will open in August.
Robin Smith, MD MBA, NeoStem's Chairman and Chief Executive Officer commented: "Securing the Santa Monica site for a new collection center in our network is an important step for us as we open collection centers in major metropolitan areas to address the demand for cutting-edge healthcare options by these sophisticated populations. The location, at the prestigious Hall Center, offers a beautiful and comforting environment where our clients can have a warm and inviting experience and will help service those clients we anticipate drawing from an awareness program being launched in September."
Dr. Smith further commented, "Many believe that adult stem cells are emerging as a modern day 'fountain of youth' and we are pleased to be at the forefront of autologous adult stem cell collection and long term storage."
"At the Hall Center, we specialize in treatments and therapies designed to help our patients stay healthy and optimize their physical and mental well being," says Harold Liebowitz, MD, the Center's Medical Director. "We are pleased and excited to bring the NeoStem process to our patients and give them the opportunity to secure bio-insurance for their medical futures. There are over 2,000 clinical trials that are using an individual's own stem cells to treat their disease such as heart disease, Lupus, MS, Crohn's disease and diabetes, just to name a few and we look forward to the future development of these important therapies."
Dr. Liebowitz was trained in Internal Medicine at USC, and worked as an Emergency and Trauma Physician for over 20 years. He has served as the Medical Director at The Centinela Hospital Fitness Institute testing professional athletes from The Lakers, Clippers, Dodgers and PGA golf tour. He was the team Doctor for The Pioneer Triathlon Team, a professional triathlon team. He served as a member of the medical Board for Tri-Fed, the governing body of the Triathlon sport. He was a member of the advisory board of Bally Health and Tennis, and 24 Hour Fitness. He also worked as a Physician at the Pritikin Longevity Center.
About the Hall Center
The Hall Center specializes in cutting-edge offerings of "Functional Medicine" -- a revolutionary science-based practice of medicine -- complimented by an array of holistic wellness services. Their innovative approach seeks to simultaneously reverse unhealthy aging on multiple levels, by integrating science-based Functional Medicine, Chinese Medicine, Homeopathy and Energy Medicine.
About Stem Collect
Stem Collect plans to develop a network of NeoStem enabled stem cell collection centers in key cities around the country. The Stem Collect network is intended to make the simple process of stem cell collection and storage available to millions of Americans where they live. As stem cell therapies continue to grow, there will be the increased need for collection and storage and Stem Collect intends to make that process simple and highly available through its network of collection centers.
About NeoStem, Inc.
NeoStem is developing a network of adult stem cell collection centers, enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times of future medical need. The Company has also recently entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells.
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements reflect management's current expectations, as of
the date of this press release, and involve certain risks and
uncertainties. The Company's actual results could differ materially from
those anticipated in these forward-looking statements as a result of
various factors. Factors that could cause future results to materially
differ from the recent results or those projected in forward-looking
statements include the "Risk Factors" described in the Company's periodic
filings with the Securities and Exchange Commission.
Robin Smith, Chief Executive Officer
|SOURCE NeoStem, Inc.|
Copyright©2008 PR Newswire.
All rights reserved